Head-to-head · Cost-Efficiency Index
ARSYNL Rx vs Luci
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
ARSYNL Rx
Cost-first shoppers who want a needle-free tirzepatide hypospray option alongside standard compounded injections, from a veteran-founded telehealth brand.
Visit ARSYNL RxLuci
Patients willing to commit to and prepay a full 12-month plan for the lowest advertised rate.
Visit LuciThe verdict
ARSYNL Rx and Luci tie on the Cost-Efficiency Index at 56/100, so neither wins outright on the numbers. For most shoppers we'd start with ARSYNL Rx (ranked #320, a hair above #326) — Cost-first shoppers who want a needle-free tirzepatide hypospray option alongside standard compounded injections, from a veteran-founded telehealth brand. But Luci is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs ARSYNL Rx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | ARSYNL Rx | Luci |
|---|---|---|
| Cost-Efficiency Index | 56/100 | 56/100 |
| Semaglutide / mo | $233/mo (starting dose, compounded) | $99/mo (starting dose, 12-month plan, compounded) |
| Tirzepatide / mo | $233/mo (starting dose, compounded) | $145/mo (starting dose, 12-month plan, compounded) |
| Semaglutide / yr (modeled) | $2,796 | $1,188 |
| Tirzepatide / yr (modeled) | $2,796 | $1,740 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #320 | #326 |
ARSYNL Rx
56/100Where the value is
- Genuinely veteran-founded — the About page names founder Arron Glysch and recounts his own hair-loss experience while deployed overseas
- Offers a needle-free tirzepatide HypoSpray with six published dose protocols (10mg-60mg total/month)
- All three GLP-1 SKUs are stated to already include the consultation and shipping in the quoted price
The tradeoffs
- No compounding pharmacy is named on any product page checked
- No individual medical director or prescriber is named anywhere accessible — only 'U.S. board certified physicians' as a category
Luci
56/100Where the value is
- Offers both semaglutide and tirzepatide
- Named clinical/telehealth partner (DrTelx) rather than zero disclosure
- Clear brand positioning (women-focused weight loss)
The tradeoffs
- Headline 'as low as' prices are explicitly 12-month-prepay-only, with true monthly cost never disclosed
- States-served list is incomplete ('CA, FL, and others')
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.